We are delighted to be hosting a parliamentary event in December 2014, hosted by John Baron MP, Chair of the All-Party Parliamentary...

On 31st October 2014 Cancer52 submitted its response to the NHS England Consultation: Proposals for a sustainable Cancer Drugs Fund. You...

The National Cancer Patient Experience Survey 2014 was published this morning. Our comment on its publication is here.

Cancer52, an alliance of 80 charities working in the field of rare and less common cancers is today (19th September 2014) publishing its...

The Joint VBA Statement, prepared alongside Genetic Alliance UK, which nearly half our members signed, was submitted on Friday 12th...

Cancer52 welcomes the new additional investment of £160 million in the Cancer Drugs Fund (CDF) announced by Health Secretary Jeremy Hunt...

Please find here Cancer52's response to the NICE Methods of Technology Appraisal Consultation, which was submitted to NICE on Tuesday...

Cancer52 is delighted to announce that Clara Mackay, Deputy CEO of Pancreatic Cancer UK, has been appointed as interim chair of Cancer52....

On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...

Making sure that rare cancers aren’t written out of the script Cancer52 published its briefing paper on the UK Strategy for Rare...